Key facts
- This page summarizes David Linetsky's Form 4 filing for Phreesia, Inc. (PHR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 Dec 2022, 15:54.
David Linetsky - 13 Dec 2022 Form 4 Insider Report for Phreesia, Inc. (PHR)
- Reporting relationship
- SVP, Life Sciences
- Issuer ticker
- PHR
- Reported as of
- 13 Dec 2022
- Net transaction value
- -$393,755
- SEC form
- 4
- Accepted by SEC
- 15 Dec 2022, 15:54:49 UTC
- Prior SEC filing
- 13 Dec 2022
- Next SEC filing
- 20 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Allison Hoffman by Power of Attorney for David Linetsky
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Linetsky filed Form 4 for Phreesia, Inc. (PHR) on 15 Dec 2022.
Change
- Previous filing in this sequence was filed on 13 Dec 2022.
- Current net transaction value: -$393,755.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PHR
transaction
Common Stock
Sale
- Transaction value
- $393,755
- Shares
- -11,377
- Change %
- -5.8%
- Price
- $34.61
- Shares after
- 185,485
- Date
- 13 Dec 2022
- Ownership
- Direct
- Footnotes
- F1, F2
PHR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,634
- Date
- 13 Dec 2022
- Ownership
- By spouse
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Footnote F2
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.50 to $35.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.